GlucanBio

About:

GlucanBio, an early stage company that repurposes non-food biomass into high-value chemicals and biomaterials

Website: http://glucanbio.com/

Top Investors: National Science Foundation, Evergreen Climate Innovations

Description:

GlucanBio technology developed from the University of Wisconsin and Center for Biorenewable Chemicals (CBiRC) at Iowa State. Our primary purpose is to produce furan derivatives from biomass with cost and performance advantages. The market opportunity is strong and relevant, not only for furfural, but also for HMF, DMF, THF and FDCA.Our team offers best-in-field expertise in catalysis, IP management, engineering scale-up, and early stage commercialization.Engaging great minds like Jim Dumesic, a world-renowned catalytic chemist, and Brent Shanks, a highly acclaimed principal in the industry, gives us an advantage in hurdling technical roadblocks.

Total Funding Amount:

$1.24M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

St Louis, Missouri, United States

Founded Date:

2012-01-01

Contact Email:

larry(AT)glucanbio.com

Founders:

Brent Shanks, James Dumesic, Peter Keeling

Number of Employees:

1-10

Last Funding Date:

2017-02-07

IPO Status:

Private

Industries:

© 2025 bioDAO.ai